Clinical Efficacy of House Dust Mite-specific Immunotherapy in Asthmatic Children-Reference-Cited by-同舟云学术

Clinical Efficacy of House Dust Mite-specific Immunotherapy in Asthmatic Children

Published:2010-02 Issue:1 Volume:51 Page:14-18
ISSN:1875-9572
Container-title:Pediatrics & Neonatology
language:en
Short-container-title:Pediatrics & Neonatology

Author:

Tsai Tzu-Chun,Lu Jen-Her,Chen Shu-Jen,Tang Ren-Bin

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference32 articles.

1. Prophylactic inoculation against hay fever;Noon;Lancet,1911

2. Hay fever and asthma: the uses and limitation of desensitization;Cooke;N Y Med J,1918

3. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite;Inal;J Investig Allergol Clin Immunol,2007

4. Position paper: immunotherapy;Malling;Allergy,1993

5. Specific immunotherapy in asthma: is it effective?;Bousquet;J Allergy Clin Immunol,1994

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review;Frontiers in Pediatrics;2023-06-15

2. Safety of subcutaneous immunotherapy in patients with severe asthma;Annals of Allergy, Asthma & Immunology;2022-11

3. Is immunotherapy safe for treatment of severe asthma;Current Opinion in Allergy & Clinical Immunology;2022-08-16

4. Immunotherapy for Asthma;Seminars in Respiratory and Critical Care Medicine;2022-06-17

5. Combination therapy of specific aeroallergens immunotherapy and omalizumab, in children with severe asthma;Allergologia et Immunopathologia;2022-03-01